Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017152254) METHODS FOR REDUCING PERINATAL MORBIDITY AND/OR MORTALITY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2017/152254 International Application No.: PCT/CA2016/050253
Publication Date: 14.09.2017 International Filing Date: 09.03.2016
IPC:
A61K 38/20 (2006.01) ,A61K 38/08 (2006.01) ,A61P 25/00 (2006.01) ,A61P 29/00 (2006.01) ,A61P 31/00 (2006.01) ,A61P 31/04 (2006.01) ,C07K 7/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
20
Interleukins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
08
Peptides having 5 to 11 amino acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04
Antibacterial agents
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
04
Linear peptides containing only normal peptide links
06
having 5 to 11 amino acids
Applicants:
OLSON, David; CA
CHU SAINTE-JUSTINE [CA/CA]; 3175 Chemin Côte-Sainte-Catherine Montréal, Québec H3T 1C5, CA
UNIVERSITE DE MONTREAL [CA/CA]; CA
THE UNIVERSITY OF ADELAIDE [AU/AU]; AU
Inventors:
OLSON, David; CA
CHEMTOB, Sylvain; CA
QUINIOU, Christiane; CA
ROBERTSON, Sarah Anne; AU
NADEAU-VALLEE, Mathieu; CA
LUBELL, William D.; CA
CHIN, Peck Yin; AU
GIRARD, Sylvie; CA
DUC, Doan-Ngoc; US
Agent:
GOUDREAU GAGE DUBUC; 2000 McGill College Suite 2200 Montréal, Québec H3A 3H3, CA
Priority Data:
Title (EN) METHODS FOR REDUCING PERINATAL MORBIDITY AND/OR MORTALITY
(FR) MÉTHODES POUR DIMINUER LA MORBIDITÉ ET/OU LA MORTALITÉ PÉRINATALES
Abstract:
(EN) A method for preventing or reducing the risk of perinatal or neonatal morbidity and mortality caused by antenatal inflammation in humans is described. This method is based on the administration of a compound of formula I or a pharmaceutically acceptable salt thereof to an expectant human mother suffering from antenatal fetal inflammation. The method prevents or reduces the risk of organ damages, including brain, lung and intestinal damages, and sequelae therefrom, in the neonates, as well as the risk of neonatal death.
(FR) L'invention concerne une méthode pour prévenir ou diminuer les risques de morbidité et mortalité périnatales ou néonatales liées à une inflammation prénatale chez l'humain. Cette méthode est basée sur l'administration d'un composé de formule I ou d'un sel de qualité pharmaceutique de ce dernier à une mère humaine enceinte souffrant d'inflammation fœtale prénatale. La méthode prévient ou diminue le risque de dommages organiques, dont des dommages au niveau du cerveau, des poumons et de l'intestin, et de séquelles de ces derniers, chez le nouveau-né, ainsi que le risque de mort néonatale.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)